Prednisone Primer for Patients
The Washington Post published a patient overview on "what Prednisone does to your body".
Read Article
RHEUM Survey>> Should rheumatologists run dedicated obesity clinics? Answer here>> https://t.co/O1DEKQLnYg
Dr. John Cush @RheumNow( View Tweet )
Obesity care is about More than the Meds.
Join us TONIGHT for the final webinar in our obesity series, exploring what comprehensive obesity care can look like in rheumatology practice.
Featuring:
Dr. Alvin Wells
Dr. Alexis Ogdie
Dr. Jack Cush
📅 Sept. 29 | ⏰ 6 PM CT
From https://t.co/wDA2RWHkeA
Dr. John Cush @RheumNow( View Tweet )
Mediterranean Diet Lowers Incident Rheumatoid Arthritis Risk
The American Journal of Clinical Nutrition has published the results of the SUN Project study, showing that long-term adherence to a Mediterranean diet (MedDiet) was associated with a substantially lower risk of incident rheumatoid arthritis (RA), but not psoriasis.
Read Article
RHEUM Survey>> Should rheumatologists run dedicated obesity clinics? Answer here>> https://t.co/O1DEKQLnYg
Dr. John Cush @RheumNow( View Tweet )
Gabapentin Use Rose as Restrictions Fell, Study Shows
Gabapentin use jumped quickly in Michigan after the drug was removed from the state's controlled substance schedule in 2024, a cross-sectional study showed.
https://t.co/xQ9MHqnNxB https://t.co/ipOWS4K61U
Dr. John Cush @RheumNow( View Tweet )
Bringing TOGETHER-PsA Into Clinical Practice
When Ms. RS came into my clinic for a new patient evaluation, she was suffering from highly active skin disease, joint swelling, pain and poor mobility. Her body mass index was 46, indicating class III obesity. A treatment plan focused solely on her inflammatory disease without addressing her
Read Article
🚨 Registration opens October 1!
RheumNow Live 2027 returns January 30–31 for our 9th Annual CME Meeting.
📍 Dallas + Online
📅 January 30–31, 2027
🎓 High-impact CME. Expert faculty. Real-world rheumatology.
The rheumatology meeting that sets the tone for the year ahead. https://t.co/1u27pab4Ee
Dr. John Cush @RheumNow( View Tweet )
Rheumatology Pay Up (9.25.2026)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
Read Article
It’s almost time. 🔥
Registration for RheumNow Live 2027 opens OCTOBER 1.
Two days of practical, engaging rheumatology education designed to challenge how you think and influence how you practice.
📅 Jan 30–31, 2027
📍 Dallas + Online https://t.co/Ju0zzYX8Tl
Dr. John Cush @RheumNow( View Tweet )
New report shows Median total cash compensation increased across all seven specialty groups in 2026; adult medical rose 7.2% - Rheumatology led one-year pay growth at 10.4% https://t.co/iuonfJRsf6 https://t.co/zybCZeNV5I
Dr. John Cush @RheumNow( View Tweet )
Early RA Referral Clinics Work (9.18.2026)
Dr. Jack Cush reviews the news and journal reports from this past week on https://t.co/ofGKCCNQnE
https://t.co/fn0L4goAMT https://t.co/F8QKs7261x
Dr. John Cush @RheumNow( View Tweet )
Gabapentin Use Rose as Restrictions Fell, Study Shows
MedPage Today
Gabapentin use jumped quickly in Michigan after the drug was removed from the state's controlled substance schedule in 2024, a cross-sectional study showed.
Read Article
🚨 Registration opens October 1!
RheumNow Live 2027 returns January 30–31 for our 9th Annual CME Meeting.
📍 Dallas + Online
📅 January 30–31, 2027
🎓 High-impact CME. Expert faculty. Real-world rheumatology.
The rheumatology meeting that sets the tone for the year ahead. https://t.co/PFZ37DlTQe
Dr. John Cush @RheumNow( View Tweet )
Steroid Delusions in Giant Cell Arteritis
A real world analysis of drug use in giant cell arteritis (GCA) patients shows that despite intending to taper patients off glucocorticoids (GC) by 24 months, 75% remained on GCs for ≥ 48 months.
Read Article
Endocrine Society - State of Obesity Science and Management
The Endocrine Society has published a scientific statement reframing obesity as a heterogeneous, chronically dysregulated fat-mass disorder, the biology of which is being tested effectively by GLP-1/GIP receptor agonists. Is this precision-medicine? We await long-term safety data, while
Read Article
Lifestyle and Incretin Therapy Advice for Rheumatologists
As GLP-1/GIP receptor agonists become standard co-management tools for obese patients with RA, PsA, axSpA, and gout, this JAMA Insights perspective by Kushner, et al. reframes lifestyle counseling as an adjunct to pharmacotherapy - a reversal of the traditional model. This has with direct
Read Article
Early RA Referral Clinics Work (9.18.2026)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Read Article
ACR Updates Osteoarthritis Guidance
ACR
The American College of Rheumatology (ACR) has released updated clinical guidance for the treatment and management of osteoarthritis (OA) of the knee, hip, and hand. The evidence-based recommendations update the 2019 ACR/Arthritis Foundation guideline and are designed to support individualized,
Read Article
Review of HLA-B27
HLA-B27 remains the dominant genetic link to spondyloarthritis (SpA) across the age spectrum, but B27 related clinical expression diverges between children and adults. New mechanistic data on autoreactive T cells, HLA-B27 misfolding, and gut-joint trafficking point to new plausible, targetable
Read Article
Data presented at 2027 ASMBS meeting showed betw 2020-2024, wt loss surgeries dropped 23%, from 230,000 in 2022 to 177,000 in 2024. Less than 1% of eligible pts are now having weight-loss surgery https://t.co/UnYIIBDdnz https://t.co/FuwnOuBUeY
Dr. John Cush @RheumNow( View Tweet )
Added IVIG is Effective in Myositis
A small randomized controlled trial demonstrates that intravenous immunoglobulin (IVIG) added to cortocosteroids lead to greater and faster improvements in patients with newly
Early RA Referral Clinics Work!
An outcomes study from the Leiden Early Arthritis Clinic (EAC) has shown substantially less diagnostic delay and better long-term outcomes when patients are referred to EAC compared to usual referrals.
Read Article
EBR Journal Club: Dapirolizumab Pegol in SLE (PHOENYCS GO)
The EBR Journal Club Companion applies my adapted version of the JAMA approach to critical appraisal to an important RCT in rheumatology. Each review covers four domains: Does this apply to my patients? What is the risk https://t.co/Pi45T99oJm
Dr. John Cush @RheumNow( View Tweet )
AI Diagnosing Rheumatic Disease?
Prof. Valmed, a large language model (LLM) cleared by European regulators for medical diagnosis, outperformed human physicians for diagnosing rheumatologic conditions in terms of speed but not accuracy, a randomized trial showed. https://t.co/WVKlRGHFL1
Dr. John Cush @RheumNow( View Tweet )
Therapeutic Updates
Lupus Nephritis
Sponsored by RheumNow
View our six video perspectives on lupus nephritis, including Management of CKD in Lupus Nephritis.
Read Post
Women in Rheumatology: Gender Issues in Disease and Management
Sponsored by Bristol Myers Squibb
Nine videos discussing gender differences in axSpA, PsA, Vasculitis, Lung Disease, Osteoporosis, Disparities in Healthcare, and Rheumatologic Activity and Treatment, are now available.
Read Post
Recent Blogs
At first, it seemed similar to many other such sessions – a circle of folding chairs, a group of colleagues whose visages exuded understanding and acceptance – but this was special. I started the meeting…. “Hi, my name is Artie.”
Read Post
At first, it seemed similar to many other such sessions – a circle of folding chairs, a group of colleagues whose visages exuded understanding and acceptance – but this was special. I started the meeting…. “Hi, my name is Artie.”
Read Post
Podcasts
Better Gout Management
